You dismiss the whole proprietary blend thing as unimportant, when in face it is a big problem. As I said, I can sell ANYTHING I want to and claim it does ANYTHING I want it to as long as I sell it as a dietary supplement. Furthermore I wouldn't have to tell anyone what is in the product as long as I hit it behind the "proprietary blend" label. Maybe you have full faith that Whole Foods is some kind of altruist and would never sell you anything with a shady label or poor science too support the efficacy of the supplement. After all, they aren't one of the "evil" corporations that only care about money and profits? Oh wait, they are.
Also a proprietary blend doesn't have to list the ingredients or the amounts of the ingredients. A normal product label doesn't even have to list the amount of the ingredients, they just list them in order from highest to lowest concentration.
You may do some research on supplements before taking them, but I know plenty of people who don't do any research and will take whatever they find if they think it will help them. They are the ones who really get screwed by proprietary blend labeling.
Facts are a very important thing here. If anyone can direct me to specific regulations please do so. Here's the informatin that should cover your concern:
Section 403® (21 U.S.C. 343®) is amended by adding at the end the following:
"(6) For purposes of paragraph ®(1)(B), a statement for a dietary supplement may be made if -
"(A) the statement claims a benefit related to a classical nutrient deficiency disease and discloses the prevalence of such disease in the United States, describes the role of a nutrient or dietary ingredient intended to affect the structure or function in humans, characterizes the documented mechanism by which a nutrient or dietary ingredient acts to maintain such structure or function, or describes general well-being from consumption of a nutrient or dietary ingredient,
"(B) the manufacturer of the dietary supplement has substantiation that such statement is truthful and not misleading, and
"© the statement contains, prominently displayed and in boldface type, the following: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.".
A statement under this subparagraph may not claim to diagnose, mitigate, treat, cure, or prevent a specific disease or class of diseases. If the manufacturer of a dietary supplement proposes to make a statement described in the first sentence of this subparagraph in the labeling of the dietary supplement, the manufacturer shall notify the Secretary no later than 30 days after the first marketing of the dietary supplement with such statement that such a statement is being made.".
§7. Dietary Supplement Ingredient Labeling and Nutrition Information Labeling.
(a) MISBRANDED SUPPLEMENTS. - Section 403 (21 U.S.C. 343) is amended by adding at the end the following: "(s) If -
"(1) it is a dietary supplement; and
"(2)(A) the label or labeling of the supplement fails to list -
"(i) the name of each ingredient of the supplement that is described in section 201(ff); and
"(ii)(I) the quantity of each such ingredient; or
"(II) with respect to a proprietary blend of such ingredients, the total quantity of all ingredients in the blend;
"(B) the label or labeling of the dietary supplement fails to identify the product by using the term `dietary supplement', which term may be modified with the name of such an ingredient;
"© the supplement contains an ingredient described in section 201(ff)(1)©, and the label or labeling of the supplement fails to identify any part of the plant from which the ingredient is derived;
"(D) the supplement -
"(i) is covered by the specifications of an official compendium;
"(ii) is represented as conforming to the specifications of an official compendium; and
"(iii) fails to so conform; or
"(E) the supplement -
"(i) is not covered by the specifications of an official compendium; and
"(ii)(I) fails to have the identity and strength that the supplement is represented to have; or
"(II) fails to meet the quality (including tablet or capsule disintegration), purity, or compositional specifications, based on validated assay or other appropriate methods, that the supplement is represented to meet.".
DSHEA Act of 1994